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An in vivo assay of synaptic function mediating human
cognition
Abstract
The contribution of dopamine to working memory has been studied extensively [1-3]. Here,
we exploited its well characterized effects [1-3] to validate a novel human in vivo assay of
ongoing synaptic [4, 5] processing. We obtained magnetoencephalographic (MEG)
measurements from subjects performing a working memory (WM) task during a
within-subject, placebo-controlled, pharmacological (dopaminergic) challenge. By applying
dynamic causal modeling (DCM), a Bayesian technique for neuronal system identification [6],
to MEG signals from prefrontal cortex, we demonstrate that it is possible to infer synaptic
signaling by specific ion channels in behaving humans. Dopamine-induced enhancement of
WM performance was accompanied by significant changes in MEG signal power, and a DCM
assay disclosed related changes in synaptic signaling. By estimating the contribution of
ionotropic receptors (AMPA, NMDA, and GABA(A)) to the observed spectral response, we
demonstrate changes in their function commensurate with the synaptic effects of dopamine.
The validity of our model is reinforced by a striking quantitative effect on NMDA and AMPA
receptor signaling that predicted behavioral improvement over subjects. Our results provide a
proof-of-principle demonstration of a novel framework for inferring, noninvasively,
neuromodulatory influences on ion channel signaling via specific ionotropic receptors,
providing a window on the hidden synaptic events mediating discrete psychological processes
in humans.
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Summary 
 
The contribution of dopamine to working memory has been studied extensively [1-3]. 
Here, we exploited its well characterized effects [1-3] to validate a novel human in vivo 
assay of ongoing synaptic [4, 5] processing. We obtained magnetoencephalographic 
(MEG) measurements from subjects performing a working memory (WM) task during 
a within-subject, placebo-controlled, pharmacological (dopaminergic) challenge. By 
applying Dynamic Causal Modeling (DCM), a Bayesian technique for neuronal system 
identification [6], to MEG signals from prefrontal cortex we demonstrate it is possible to 
infer synaptic signaling by specific ion channels in behaving humans. Dopamine-induced 
enhancement of WM performance was accompanied by significant changes in MEG 
signal power, and a DCM assay disclosed related changes in synaptic signaling. By 
estimating the contribution of ionotropic receptors (AMPA, NMDA and GABAA) to the 
observed spectral response, we demonstrate changes in their function commensurate 
with the synaptic effects of dopamine. The validity of our model is reinforced by a 
striking quantitative effect on NMDA and AMPA receptor signaling that predicted 
behavioral improvement over subjects. Our results provide a proof-of-principle 
demonstration of a novel framework for inferring, non-invasively, neuromodulatory 
influences on ion channel signaling via specific ionotropic receptors, providing a window 
on the hidden synaptic events mediating discrete psychological processes in humans.    
 
Highlights 
 
 We present a DCM capable of assaying neurotransmitter function during human cognition 
 We demonstrate this using dopaminergic modulation of working memory and MEG 
 We find changes in ionotropic receptor function commensurate with DA enhancement  
 We uncover quantitative effects that can predict individual behavioral improvements 
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Results 
 
In this study, we tested whether DCM could recover changes in neurotransmission induced 
experimentally by the actions of the catecholamine dopamine. This inference about cellular 
processes from measured MEG data aims to provide a demonstration of the potential utility of 
DCM as a “mathematical microscope” that can probe synaptic quantities from the distant 
perspective of non-invasive electrophysiological data. Our biophysically interpretable DCM 
quantifies synaptic signaling at excitatory (glutamatergic) synapses with both fast AMPA and 
slow nonlinear NMDA receptors, and at inhibitory synapses, employing fast GABAA 
receptors. The ensuing neuronal population dynamics are characterized by differential 
equations describing the temporal evolution of membrane potentials and ion channel 
conductances that underpin field potentials, including those recorded by MEG [6].  
 
Working Memory under L-Dopa 
We recorded MEG signals from 18 participants performing a WM task on two separate 
occasions; in a placebo-controlled randomized within-subject design involving administration 
of the dopamine precursor levodopa (L-Dopa). To assess working memory we used a change-
detection paradigm (see Figure 1A). On placebo, subjects performed close to a 
psychophysically pre-titrated level (70.60 ± 2.02 (SEM) percent correct responses). We 
predicted that L-Dopa administration (100 mg) would induce a behavioral improvement in 
WM: This was indeed observed, with a small but significant increase in overall WM accuracy 
(74.04 ± 2.07; p< 0.05 one tailed, paired t test, Figure 1B). 
 
MEG Spectral Characteristics during Working Memory  
To localize the neuronal correlate of this behavioral effect, we first examined the MEG signal 
profile during the maintenance period of the WM task. Specifically, we tested whether any of 
five frequency bands, delta (2-4 Hz), theta (4-8 Hz), alpha (8-16 Hz), beta (16-32 Hz) or 
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gamma (32–60 Hz) exhibited sustained activity that was greater for memory than no memory 
conditions. A differential pattern was observed within delta, theta and alpha bands (p < 0.001, 
Figure 1C) at predicted locations over prefrontal sensors. Having established the frequencies 
manifesting sustained effects, we source-localized these frequencies (2-16 Hz) for each 
subject individually (for details see Supplemental Information). To address the key question 
of whether, and how, WM-induced activity was modulated by L-Dopa we examined the 
contrast of WM-by-drug interaction and observed significant effects in a focal area of the 
right superior frontal gyrus (SFG; peak x = 32, y = 4, z = 68; t = 2.79, p = 0.006, Figure 1D). 
This region exhibited prominent theta activity during memory maintenance, with spectra 
under L-Dopa exhibiting a higher amplitude peak at 6–8 Hz (Figure 1D). Our ensuing (DCM) 
analysis focused on the spectral responses in this region: 
 
Synaptic Assay using DCM 
In traditional delayed match-to-sample WM tasks, the delay period is accompanied by 
maintenance activity in PFC thought to reflect reverberatory activity in pyramidal cell 
networks, which retain stimulus related information for the period when the target is off 
screen. The synaptic dynamics of several different transmitter systems and receptor subtypes 
interact to support this sustained activity. Glutamatergic action at NMDA receptors is critical 
in maintaining recurrent reverberatory dynamics within the pyramidal cell network [7], as this 
non linear voltage-gated ion channel has a slow time constant providing a near constant 
synaptic drive [8]. Conversely, AMPA signaling induces fluctuations in cell assembly firing 
and a susceptibility to interference [8, 9]. Strong network inhibition has also been used to 
explain persistent activity associated with stimulus selective attractors [10, 11]. Our critical 
analysis involved fitting a biophysically plausible DCM to SFG spectral responses to estimate 
synaptic parameters underpinning sustained (delay period) activity and how they are 
modulated by dopamine. Dopamine, particularly through its actions at D1 receptors [12, 13] 
modulates the balance of excitation and inhibition in the PFC via diffuse afferent projections 
from midbrain neurons [14], that stabilize persistent activity. This is attributed to two known 
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effects of dopamine on PFC function during working memory: first, an enhancement in the 
conductance of GABAA [15] and NMDA [16, 17] channels; with the latter requiring some 
(optimal) level of excitation mediated by fast ionotropic (AMPA) receptors [18]. Secondly, an 
attenuation of post-synaptic responses of layer III pyramidal cells to exogenous glutamatergic 
inputs (from other cortical areas, or from thalamus via layer IV granular cells) [19], thus 
reducing the influence of remote sources on local circuit activity. It is these mechanisms that 
we hoped to access quantitatively via our parameter estimates. 
In our model, excitatory spiny stellate cells in layer IV received extrinsic (cortical and 
thalamic) inputs in the form of passive exogenous currents. We constructed a layered 
columnar architecture with glutamatergic projections from the input layer IV to pyramidal 
cells occupying supra- and infra-granular layers, with excitation mediated by both AMPA and 
NMDA receptors postsynaptically (Figure 1D). Sustained activity of these pyramidal cells 
arises from feed-forward processing via recurrent collaterals and reciprocal connections to the 
spiny stellate cells. Inhibition was provided by inhibitory interneurons occupying supra- and 
infra-granular layers. These GABAergic neurons targeted ionotropic GABAA receptors at 
pyramidal and stellate cells and, in turn, received glutamatergic inputs from pyramidal cells 
via NMDA and AMPA receptors (Figure 1D). Our modeling approach is summarized in 
Supplemental Information, and all details concerning the mathematical properties of 
our model, its physiological plausibility and statistical procedures for fitting can be 
found in previous methodological papers [6, 20-22]. 
To uncover the synaptic mechanisms underlying the observed drug-by-memory interaction, 
two DCMs (memory and no-memory) were inverted (fitted), using the SFG spectral data from 
each subject. Condition-specific effects, reflecting differences in L-Dopa and placebo-induced 
processing, were modeled via a modulation of synaptic parameters (see Figure 2C and 
Supplemental Information for details), including the strengths of presynaptic inputs to and 
postsynaptic conductances of (i) AMPA and NMDA receptors at pyramidal cells and 
inhibitory interneurons, and (ii) GABAergic receptors at pyramidal cells.  Additionally, we 
modeled changes in parameters encoding (iii) the nonlinearity  of NMDA receptors and (iv) 
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extrinsic (cortical and thalamic) input u to layer IV cells. The spectral data predicted by the 
model recapitulated the increased theta band activity on L-Dopa. Clearly, changes in several 
or all of the synaptic parameters could contribute to theta band differences: We quantified 
the sensitivity of theta responses to each parameter. Testing at the peak of the 
interaction (6 Hz) we showed that the only parameter with a differential contribution to 
theta under L-Dopa and placebo was the nonlinearity parameter associated with NMDA 
receptors. Importantly, across the 2-16 Hz frequency range, the sensitivity profile was a 
different shape for each parameter, meaning that they can differentially promote or 
suppress spectral power (see Figure S2).  
Our key question was whether pharmacologically induced changes in model parameters 
depended on the psychological state (i.e., memory condition). Of particular interest were 
those parameters representing processes expected to be modulated by dopamine. These were 
the AMPA pyramidal to stellate coupling, γ1,3, NMDA nonlinearity α, GABAergic connection 
strength γ3,2 and extrinsic input parameter u (Figures 1D, 2C). Hence, we tested for task-
induced differences in the DCM parameters on dopamine, using a repeated measures 
ANOVA with, task (memory vs. no memory) and parameter (γ1,3, α, γ3,2 and u) as within 
subject factors. Crucially, we could show that on dopamine there was a task-dependent 
difference in parameter estimates (p = 0.009). Analysis of the full (placebo controlled) drug  
task interaction showed consistent differences for two of the model parameters of interest, 
both of which relate to glutamatergic transmission (Figure 2C): Testing in the direction of 
hypothesized change using a paired one-tailed t test we observe that the increase in the 
sensitivity (nonlinearity) α of NMDA receptors induced by L-Dopa vs. placebo was further 
enhanced during Memory compared to No Memory trials (p = 0.006). In contrast, L-Dopa vs. 
placebo decreased the parameter u encoding exogenous (glutamatergic) input to layer IV, and 
this difference was significantly more pronounced during Memory vs. No Memory trials (p = 
0.03). Corresponding tests of the interaction for parameters controlling GABAergic 
connection strength (γ3,2; p = 0.06) and AMPA-mediated coupling from pyramidal to stellate 
cells (γ1,3; p > 0.1) were not significant. 
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Correlation between Behavioral Performance and Synaptic Assay 
A key test of the validity of our estimates is whether the synaptic changes inferred by DCM 
predict observed behavioral improvements under L-Dopa. Given the antagonistic roles of 
NMDA and AMPA receptors for enabling reverberatory activity during WM [8], where 
NMDA to AMPA ratios have been proposed to be crucial, we focused on parameter estimates 
related to these receptor types. We found significant correlations between the change in 
behavioral accuracy under L-Dopa and the degree by which L-Dopa both decreased AMPA 
coupling (R = -0.51, p = 0.03, Figure 2D) and increased NMDA nonlinearity (R = 0.59, p = 
0.01, Figure 2D). Put simply, subjects whose memory performance improved most on L-
Dopa had greater NMDA gating and decreased AMPA signaling. In terms of its spectral 
signature this performance enhancement was significantly correlated with a decrease in theta 
power for Memory – No Memory trials for L-Dopa relative to placebo states (p < 0.036; 
Supplemental Information Figure S4).  
 
Discussion 
 
In this study we employed a “minimum simple model approach” [24], describing a candidate 
subset of possible synaptic mechanisms that may be modulated by L-Dopa. These 
mechanisms, which included synaptic transmission via AMPA, NMDA, and GABAA 
receptors and glutamatergic inputs to layer IV, were chosen because of their important roles 
in working memory delay period activity, as documented in both electrophysiological [25, 26] 
and computational studies [27]. Other possible effects induced by L-Dopa, e.g. an interaction 
with serotonergic transmission [28, 29], were not considered and the specificity of the assay 
will require further testing. The sensitivity of the assay, however, was revealed by specific 
task-selective changes in cortical excitability in terms of dopamine-dependent changes in 
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synaptic processes. These changes were consistent with the predicted modulatory effects of 
dopamine [8, 9, 30-32].  
DCM is a general framework for testing mechanistic hypotheses of how measured signals 
were generated and, in so doing, can accommodate models of different types. Here we 
employed a DCM that followed closely the principles of well-established models of working 
memory. Computational models of the effects of dopamine on working memory demonstrate 
that prefrontal neurons settle on high activity attractor states during memory maintenance, and 
that this dynamic behavior is caused by increased currents at NMDA and GABAA associated 
channels, and decreased currents at AMPA receptor associated channels [27, 31, 33]. The 
neural mass model underpinning our DCM contains the same types of active channels and 
cell types (where we also include stellate cells in the PFC’s layer IV [34]) and uses 
differential equations that are formally similar to the leaky integrate and fire models of Brunel 
and Wang [33] (with an identical nonlinearity at NMDA receptors). Moreover, we model the 
relative contribution of these channels in a similar way, using parameters that specify the 
impact of presynaptic inputs on postsynaptic responses mediated by specific channels (Figure 
S1). However, in our analyses, we must consider a measurement obtained from an ensemble 
of tens of thousands of neurons. DCM affords inference on microscopic states from 
macroscopic data by employing a mean-field approximation [35]. This approximation 
replaces the time-averaged discharge rate of individual stochastic neurons with a common 
time-dependent average population measure (see [22] for a full treatment of this mean field 
approach).  
Our estimates of L-Dopa effects on synaptic transmission via several specific receptors 
correspond nicely to established neurophysiological effects of dopamine during working 
memory tasks (Figure 2C). In particular, our modeling results replicate the known effects of 
NMDA and AMPA receptor function on delay period activity; where L-Dopa increases post-
synaptic responses mediated by NMDA receptors and decreases AMPA receptor mediated 
coupling between pyramidal cells and stellate cells. Moreover, we found that L-Dopa 
decreased the impact of exogenous input from remote sources during memory maintenance; 
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this is likely to reflect a diminution of noisy input from outside the circuit [19]. If the L-Dopa 
induced enhancement of WM we observe is due to enhanced reverberatory activity in 
prefrontal circuits, one would expect to find a significant correlation between the magnitude 
of our parameter estimates and behavior. This is exactly what we found: across subjects, 
drug-induced changes in parameter estimates encoding the effects of NMDA and AMPA 
signaling were significantly correlated with individual behavioral performance (Figure 2D). 
 
Our wider strategic goal was to provide a proof of principle that it is possible to link human 
behavior via neural circuit models to specific synaptic signaling mechanisms. Explaining a 
behavioral effect in terms of synaptic mechanisms within specific brain regions provides us 
with a novel non-invasive framework for quantifying hidden biological mechanisms 
underlying measured data. Our approach may have considerable potential, not only for 
understanding fundamental cognitive processes, but also for unraveling pathophysiological 
mechanisms in psychiatric and neurological diseases. 
 
 
Experimental Procedures  
 
Subjects and pharmacological manipulation 
18 right-handed, healthy volunteers (9 female, aged 27 ± 8 yrs) were studied. They attended 
on two sessions, exactly one week apart, where they were given either 100mg of L-Dopa 
dissolved in fruit juice or a fruit juice placebo one hour prior to scanning. The experimental 
procedures were approved by the local Ethics Committee. 
 
Dynamic Causal Modeling 
For our DCM analysis, we extracted estimates of responses during the delay period from right 
superior frontal gyrus (SFG) (see Supplemental Information). Two DCMs of identical 
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structure were inverted per subject: one model was fitted to Memory trial data (on L-Dopa 
and placebo) and the other was fitted to No Memory trial data. The posterior densities 
obtained by model inversion (and drug-induced differences) were subsequently used for 
inference on parameters [43, 44], enabling us to quantify the likely neural mechanisms 
generating different spectra over the four conditions. Note that by fitting separate DCMs to 
the two memory conditions, we allowed all parameters to change; however, the effects of L-
Dopa were modeled within each DCM, with changes in a small plausible set of parameters. 
The equations describing this model are given in Supplemental Information. 
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Figure Legends 
 
Figure 1 Experimental task and delay period activity 
(A) The experimental design comprised blocks of “Memory” and “No Memory” trials. We 
ran six blocks of alternating memory and no memory conditions, comprising forty-trials per 
block to yield a total of 240 trials per session. Drug and block order was counterbalanced 
across subjects. The first trial of each block was preceded by a cue indicating a “Memory” or 
“No Memory” condition and the background color was set to black for “Memory” blocks and 
grey for “No Memory” blocks. Each trial consisted of a fixation cross (300 ± 50 msec) 
followed by the target stimulus of a colored square array. These arrays consisted of randomly 
colored squares (2.5° x 2.5°; red, blue, green, yellow, grey, cyan,  and violet, with the number 
of squares corresponding to titrated load) in a randomized position. The target stimulus 
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appeared for 300 ms and was followed by a delay period of 4000 ms, during which subjects 
had to retain the target memory array. This was followed by the onset of the probe image, 
after which subjects had 2000 ms to respond with a “match” or “no match” button press. 
Match and no-match trials occurred randomly, with equal probability. “No Memory” blocks 
contained the same stimuli but subjects were instructed to simply press the “match” button on 
presentation of the second array. Accuracy was computed as the percentage of correct button 
press responses in “Memory” blocks. Before drug administration on week 1, each subject was 
tested using 50 sample trials with varying memory load (2 – 6 squares) to titrate accuracy 
levels. For each subject, the memory load with accuracy closest to 70% was used for the 
subsequent MEG experiment. (B) A pre-MEG test titrated individual memory load to achieve 
70% accuracy. During MEG recordings, placebo-treated subjects performed with an accuracy 
close to titrated levels (70.60 ± 2.02, s.e.m.) and improved significantly on L-Dopa (74.04 ± 
2.07; *p <  0.05 one tailed paired t test,). (C) We obtained scalp-time statistical parametric 
maps (SPMs) by testing for increases in sustained activity at particular bands during 
memory retention (see Supplemental Information). Sustained increases in delta and theta 
responses were found over prefrontal sites, while sustained alpha occurred primarily over 
occipito-parietal sites. (Beta activity, while significantly greater at the beginning of the 
delay period, did not show a sustained effect during maintenance, and no effect was 
expressed in the gamma band. All other bands showed sustained increases). The images 
are maximum intensity projection images (MIPs) showing t-statistics for a significance level 
of p < 0.01 for clusters with more than 10 pixels; colorbars denote t values. In the top panel, 
SPMs of the t-statistic are depicted for all sensors (left to right corresponding to posterior to 
anterior) over time. The bottom panels depict these same (largest) statistical values over time 
with corresponding sensor locations. (D) Left: SPM of the interaction between memory and 
dopamine (displayed at p < 0.01 uncorrected), where the peak is observed in right superior 
frontal gyrus (peak x = 32, y = 4, z = 68; t = 2.79, p = 0.006 uncorrected within a mask of 
inferior, middle and superior frontal gyri). The SPM is rendered on a canonical structural 
MRI scan, displayed on a horizontal section at z = 66. We also tested for the orthogonal 
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main effect of memory and found significant increases in activity for memory compared 
to no-memory trials in bilateral prefrontal cortex, maximal over right dorsolateral 
prefrontal cortex (peak x = 22, y = 52, z = 0; t = 3.95, p = 0.001 uncorrected within a 
mask of inferior, middle and superior frontal gyri; Figure S3). Middle: Average spectral 
density for “Memory” and “No Memory” trials, on L-Dopa (blue and red lines, respectively) 
and on placebo (green and cyan, respectively), in the right superior frontal gyrus, averaged 
across subjects (shaded regions report the s.e.m.). Right: The interaction ([Memory L-Dopa – 
No Memory L-Dopa] – [Memory placebo – No Memory placebo]) plotted from the spectra 
(middle panel) averaged across subjects, shows a negative theta response when retaining a 
memory on L-Dopa relative to placebo. This is effectively the difference in the differences 
among the four condition specific responses. Bottom: Macrocolumnar architecture used to 
model right SFG responses in the DCM analysis. The model comprises three interconnected 
cell layers, where spiny stellate cells occupy granular layer IV (population 1) whereas 
inhibitory interneurons (population 2) and pyramidal cells (population 3) occupy supra- and 
infragranular layers. For clarity, neurons in the infragranular layer are omitted. Extrinsic (e.g., 
thalamic) input enters the granular layer and signals propagate throughout the macrocolumn 
via intrinsic coupling parameters γto, from. The model’s parameters are associated with 
particular ionotropic receptor types: AMPA and GABAA at all cell types and NMDA at 
pyramidal cells and inhibitory interneurons. These synaptic parameters γ represent lumped 
coupling parameters that quantify the collective effect of a number of biophysical 
processes such as receptor binding and transmitter reuptake. The modeled SFG 
response is assumed to arise most prominently (80%) from the pyramidal cells’ 
depolarization due to their dendritic organization, with a 20% contribution from the 
membrane potentials of the inhibitory interneurons and stellate cells. 
 
Figure 2 DCM predictions and parameter estimates 
(A) Predicted and observed spectral responses from a single subject. Left: the responses of the 
Memory DCM showing predicted spectral responses with 90% Bayesian credible intervals for 
16 
 
both L-Dopa and placebo conditions. These credible intervals include the observed spectrum 
at all frequencies. Right: Observed and predicted spectral responses (again with 90% credible 
intervals) for No Memory trials. Again, the credible intervals of our model predictions include 
the observed spectra. (B) NMDA nonlinear function (Eq. 2, Experimental Procedures) 
illustrated for increasing values of parameter α. As α increases, the voltage-dependent 
magnesium switch becomes highly non-linear. (C) Synaptic measures illustrating the 
difference in maximum a posteriori (MAP) B parameter estimates from the Memory and No 
Memory DCMs. Significant differences were tested with one-tailed t test in hypothesized 
directions (p < 0.05) and were observed for two parameters, reflecting an increase in NMDA 
nonlinearity α and decreased exogenous (glutamatergic) input u under L-Dopa vs. placebo, 
while subjects engaged in working memory relative to a control condition. (D) Left: Using the 
difference in maximum a posteriori (MAP) B parameter estimates, individual differences in 
AMPA coupling γ1,3, show a significant negative correlation with behavioral improvement on 
L-Dopa (R = -0.46 p = 0.027 Pearson one-tailed linear correlation). Right: while the 
interaction in NMDA non-linearity α show a significant positive correlation with behavioral 
improvement on L-Dopa (R = 0.55, p = 0.009 Pearson one-tailed linear correlation). 
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 Figure S1. Neural Mass Model Equations of Motion 
Morris Lecar-type differential equations (Moran et al. 2011) describing the time 
evolution of current and conductance at stellate cells (grey hexagon), inhibitory 
interneurons (purple circle) and pyramidal cells (green triangle). In this model, all cell 
types possess AMPA receptors, GABAA receptors are found at the stellate cells and 
pyramidal cells and NMDA receptors at pyramidal cells and inhibitory interneurons.  
 
 
  
Figure S2 Sensitivity Analysis 
a) Here, we show the results of a contribution or sensitivity analysis, using the a 
posteriori estimates from the DCM of Memory trial data on and off L-Dopa from each 
subject. The results show the derivative of the predicted spectral response in the theta 
band with respect to the model’s key biophysical parameters; i.e. the deviation of power 
in the theta band (at 6 Hz) with small deviations (increases) in parameters, [γ1,3], [α], [γ3,2 
] and [u] encoding AMPA responses, NMDA nonlinearity, GABA responses and 
exogenous input respectively. Note that two of these parameters dominate in controlling 
the power of the theta response. These are the AMPA parameter and GABA parameter, 
which enhance and diminish the power at 6Hz respectively. These derivatives are 
several orders of magnitude greater than those for the NMDA or input parameters. 
However the NMDA nonlinearity is the only parameter that contributes differentially 
under L-Dopa and placebo. At the optimum parameters under L-Dopa, changes in the  
parameter lead to reduced diminution of theta, as compared to changes evaluated for 
the optimum parameters under the placebo condition (*p = 0.038 uncorrected; paired 
two-tailed t test over subjects). 
 b) Different sensitivity profiles for each parameter across the fitted spectral range. A 
sensitivity analysis across all frequencies shows that during memory maintenance 
AMPA channels, [γ1,3] differentially promote theta activity (peak at 5-6Hz), while small 
increases in the NMDA parameter], [α]  also differentially effect theta/alpha bands 
(peak at 8Hz) but here the effect is to reduce the power at these frequencies. These 
AMPA effects are similar across the drug states, while the NMDA effect is greater for 
the L-Dopa network. A small increase in the GABA parameter, [γ3,2] reduces power at 
all but the highest frequencies, whereby a qualitative change in sensitivity occurs at low 
beta frequencies (~13-16 Hz). Here GABA promotes the spectral power. This effect is 
more pronounced for placebo relative to L-Dopa architectures. An increase in input [u] 
also promotes power, preferentially in the alpha band (peak at 7-8Hz), where again this 
effect is higher in the placebo network.  
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Fig S3 Main effect of Memory 
SPM of main effect of memory from source localized data rendered onto a canonical 
cortical surface, displayed at p < 0.01 uncorrected. Peak activity is observed in the right 
dorsolateral prefrontal cortex (peak x = 22, y = 52, z = 0; t = 3.95, p = 0.001 uncorrected 
within a mask comprising inferior, middle and superior frontal gyri). 
 
 
 
Th
et
a 
Po
w
er
 In
te
ra
ct
io
n 
a.
u.
 
R= -0.49 
p = 0.036
Performance Increase
-10 -5 0 5 10 15 20
-4
-3
-2
-1
0
1
2
3
4S4
 
Fig S4 Correlation between Performance and Theta Band Power 
Over subjects, individual performance increase on L-Dopa is inversely correlated with 
theta power (measured at the theta peak: 6Hz) for Memory relative to No Memory trials 
on drug relative to placebo. 
 
MEG Analysis 
Task and MEG acquisition 
MEG recordings were made in a magnetically shielded room using a 275-channel CTF 
system with SQUID-based axial gradiometers (VSM MedTech Ltd., Couquitlam, BC, 
Canada). The task involved a change-detection, visuo-spatial working memory task, where 
subjects retained a spatial array of colored squares [1] (see main text Figure 1A).  
 
Data pre-processing and statistical analysis 
MEG data were epoched to obtain 4000 ms data segments corresponding to each trial’s delay 
period. Data were corrected for artifacts using thresholding and then down-sampled to 200Hz 
(the analysis routines used for the present paper are available in the academic open source 
package SPM8; http://www.fil.ion.ucl.ac.uk/spm/). 
 
SPM Analysis 
Time-Frequency characterizations from the maintenance period for frequencies from 2-60Hz 
were rescaled logarithmically and averaged across memory and drug conditions resulting in 4 
three-dimensional summary images per subject. These data were then converted to two-
dimensional images by averaging within conventionally defined frequency bands, to produce 
band limited sensor  time representations at delta (2-4 Hz), theta (4 – 8 Hz), alpha (8 – 
16Hz), beta (16 – 32 Hz) and gamma (33 - 60) frequencies. We computed a Memory – No 
Memory contrast image for each subject and entered these into a second-level (between 
subject) random effects SPM analysis using a one-sample t test. Using an uncorrected 
statistical threshold of p < 0.01 and a cluster size of ten pixels, we observed an increase in 
sustained activity at particular bands during memory retention (Figure 1C). 
 
For our source space analysis, the inverse solution was calculated using a time window from 
800 – 3200 ms during the maintenance period. SPM8’s multiple sparse priors routine was 
used to estimate the cortical source of this activity [2]. A contrast of response power over 2 – 
16Hz (the frequencies of interest obtained from the sensor level analysis) was computed for 
each memory and drug condition separately. Source activity measures were then interpolated 
into MNI voxel space [3]. We then tested for two effects of interest in source space, within an 
a priori region of interest, (comprising inferior, middle and superior frontal gyri) employing a 
random effects SPM analysis as above, using one sample t tests across subjects. This region 
was defined anatomically, using a mask image from the Wake Forest University PickAtlas 
[4]. After localizing these effects, we examined the effects of memory retention independent 
of the drug condition; using subject-specific contrast images for average [Memory – No 
Memory] conditions and the effects of drug on memory retention, to examine the interaction 
[(Memory – No Memory)L-Dopa – (Memory – No Memory)placebo].  
 
 
Source Extraction 
For a smooth estimate of the delay period signal from SFG (centered on x = 32, y = 4, z = 68; 
MNI coordinates), we employed FieldTrip’s beamforming source extraction method with 
regularization of 0.01% (http://www.ru.nl/neuroimaging/fieldtrip/). Frequency domain 
representations were constructed from this signal in the time window 800 – 3200 msec. These 
spectral responses, which were consistent with previous electrophysiological studies of 
working memory [5-7], were used for the inversion of our DCM.  
 
 
Dynamic Causal Modeling 
The principle of applying a mathematical model to infer the likely causes of measurements 
underpins many neurophysiological analyses, for example general linear or dynamic models 
that relate hemodynamic measurements [8] to underlying neuronal population activity. 
Dynamic Causal Modeling (DCM) is one such framework that employs Bayesian techniques 
to infer hidden (unobservable) neuronal mechanisms and architectures from neuroimaging or 
electrophysiological data [9]. 
 
Our mean-field model predicting neural activity in the SFG was based on the Morris-Lecar 
model [10]. The dynamics of postsynaptic responses are described in analogy to an equivalent 
RC circuit where, using Kirchhoff’s current law, capacitive synaptic current flow equals the 
summed active and passive currents across the membrane [11,12]. The active currents across 
the postsynaptic membrane include ligand-gated excitatory (Na+) and inhibitory (Cl-) ion flow 
mediated by fast AMPA and GABAA receptors and slower NMDA receptors [22], depending 
on cell type. The magnesium block of NMDA receptors requires a sufficient transmembrane 
potential difference for its removal, and hence these channels are voltage-gated and non-
linear. In our model, the NMDA conductance is augmented by a parameterized nonlinear 
sigmoid gain function fMG(V) (Eq. S1). Reversal potentials VE, VI and VNMDA, were fixed at 60 
mV, -90 mV and 60 mV, respectively, and membrane capacitance at 8 uF. A potassium leak 
current was used to account for all passive ionic currents, with reversal potential VL of -70 
mV. The model also included a driving current input u, entering at the granular layer:  
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The conductances of the ligand-gated ion channels in our model are described by additional 
differential equations. These conductances g reflect the number of open channels, which are 
hidden states that depend on the presynaptic input ς, the coupling of presynaptic input to the 
postsynaptic response γ, the number of open channels and the channel’s time-constant ( /1 ) 
with prior values of 4 ms, 16 ms and 100 ms, for AMPA, GABAA and NMDA receptors 
respectively.  
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These dynamics at the single neuron level are stochastic, with the term Г denoting Gaussian 
state-noise (fluctuations). As established by Marreiros et al [12], we can transform these 
single-neuron stochastic dynamics to a deterministic generative model of ensemble or 
population dynamics using the Fokker-Planck formalism. For the DCM, the prefrontal 
cortical region comprises three neuronal populations [13, 14], excitatory spiny stellate cells, 
pyramidal cells and inhibitory interneurons, coupled through intrinsic synaptic connections 
(see main text Figure 1D and Figure S1) with fast AMPA and GABAA receptors in all 
populations and NMDA receptors in pyramidal and inhibitory populations [15]. In a system 
of connected neuronal ensembles, the input to an ensemble i is the expected firing rate from 
the source ensemble j: The coupling of this presynaptic input to a postsynaptic response is 
represented by the parameter γi,j which subsumes various biophysical processes such as 
receptor binding and transmitter reuptake. 
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The sigmoid function )(  represents the cumulative distribution function of the presynaptic 
depolarization density, V = ( ) ( )( , )N j j  , around a threshold potential RV = -40mV, which 
determines the proportion of afferent cells firing (see Marreiros et al).   
Given this set of differential equations we can apply their associated transfer functions in 
frequency space to the power spectrum of fluctuating inputs and predict the output spectrum. 
This allows us to establish a mapping from the system parameters to the predicted frequency 
spectrum [11]. Together with plausible assumptions about the form of the spectrum of 
neuronal fluctuations, this mapping furnishes a likelihood model that can be combined with 
prior densities on the parameters to yield a generative model of spectral responses (for details, 
see Moran et al. 2011). This model can be inverted (i.e.,, fitted to measured data; here the 
spectral density from the cortical source) to obtain the posterior densities of the parameters. In 
DCM, a variational Bayesian scheme (Variational Laplace) is used to approximate the 
posterior density over parameters by maximizing the negative free energy; a bound on the 
log-model evidence; see [16] for details. The parameters operate as scaling values on preset 
values [12]. Free parameters include gains on each channel’s time constant ( /1 ), intrinsic 
coupling measures γi,j, extrinsic cortical input u, the NMDA channel nonlinearity parameter α 
and neuronal noise, represented by a mixture of white and pink noise components (parameter 
set A). Based on known neurophysiological effects of dopamine on different ion channels, a 
subset of these parameters was augmented by additional condition-specific scaling parameters 
to allow for drug-specific effects. These modulatory parameters (parameter set B) included 
changes in stellate to pyramidal cell coupling via AMPA and NMDA receptors (γ3,2), 
pyramidal to pyramidal cell coupling via AMPA and NMDA receptors (γ3,3), pyramidal to 
stellate cell connectivity via AMPA receptors only (γ1,3), inhibitory interneuron to pyramidal 
cell coupling via GABAA receptors (γ3,2), the NMDA nonlinearity (α) and extrinsic cortical 
input (u). The B parameters could take positive or negative values, representing an increase or 
decrease of the corresponding A parameters under L-Dopa. Prior densities on all parameters 
were found from a first pass of DCM for all subjects, where the posteriors from the best data-
fit were used as priors in all subsequent analyses.  
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